nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—AR—scrotum—urinary bladder cancer	0.108	0.282	CbGeAlD
Fludrocortisone—AR—penis—urinary bladder cancer	0.0485	0.127	CbGeAlD
Fludrocortisone—NR3C1—urine—urinary bladder cancer	0.0234	0.0613	CbGeAlD
Fludrocortisone—NR3C2—prostate gland—urinary bladder cancer	0.0157	0.041	CbGeAlD
Fludrocortisone—Aseptic necrosis—Methotrexate—urinary bladder cancer	0.0147	0.0365	CcSEcCtD
Fludrocortisone—Cutaneous hypersensitivity—Gemcitabine—urinary bladder cancer	0.0136	0.0337	CcSEcCtD
Fludrocortisone—NR3C2—seminal vesicle—urinary bladder cancer	0.0132	0.0347	CbGeAlD
Fludrocortisone—AR—prostate gland—urinary bladder cancer	0.0116	0.0304	CbGeAlD
Fludrocortisone—Glucose tolerance impaired—Cisplatin—urinary bladder cancer	0.0115	0.0285	CcSEcCtD
Fludrocortisone—NR3C2—smooth muscle tissue—urinary bladder cancer	0.0111	0.029	CbGeAlD
Fludrocortisone—NR3C2—Preimplantation Embryo—AQP3—urinary bladder cancer	0.011	0.0521	CbGpPWpGaD
Fludrocortisone—NR3C2—renal system—urinary bladder cancer	0.0107	0.0279	CbGeAlD
Fludrocortisone—NR3C2—Preimplantation Embryo—CDX2—urinary bladder cancer	0.0105	0.0499	CbGpPWpGaD
Fludrocortisone—NR3C2—urethra—urinary bladder cancer	0.0105	0.0274	CbGeAlD
Fludrocortisone—AR—seminal vesicle—urinary bladder cancer	0.0098	0.0257	CbGeAlD
Fludrocortisone—Papilloedema—Cisplatin—urinary bladder cancer	0.00972	0.0241	CcSEcCtD
Fludrocortisone—NR3C2—female reproductive system—urinary bladder cancer	0.00854	0.0224	CbGeAlD
Fludrocortisone—AR—epithelium—urinary bladder cancer	0.00852	0.0223	CbGeAlD
Fludrocortisone—NR3C1—prostate gland—urinary bladder cancer	0.00839	0.022	CbGeAlD
Fludrocortisone—AR—smooth muscle tissue—urinary bladder cancer	0.00821	0.0215	CbGeAlD
Fludrocortisone—NR3C1—Endoderm Differentiation—BPTF—urinary bladder cancer	0.0082	0.0389	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDX1—urinary bladder cancer	0.00807	0.0382	CbGpPWpGaD
Fludrocortisone—AR—renal system—urinary bladder cancer	0.0079	0.0207	CbGeAlD
Fludrocortisone—AR—urethra—urinary bladder cancer	0.00776	0.0203	CbGeAlD
Fludrocortisone—NR3C2—vagina—urinary bladder cancer	0.00773	0.0202	CbGeAlD
Fludrocortisone—NR3C1—seminal vesicle—urinary bladder cancer	0.0071	0.0186	CbGeAlD
Fludrocortisone—Skin hyperpigmentation—Thiotepa—urinary bladder cancer	0.00663	0.0165	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Mitomycin—urinary bladder cancer	0.00657	0.0163	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Valrubicin—urinary bladder cancer	0.00644	0.016	CcSEcCtD
Fludrocortisone—AR—female reproductive system—urinary bladder cancer	0.00633	0.0166	CbGeAlD
Fludrocortisone—Cardiac failure congestive—Mitomycin—urinary bladder cancer	0.00627	0.0156	CcSEcCtD
Fludrocortisone—NR3C1—epithelium—urinary bladder cancer	0.00617	0.0162	CbGeAlD
Fludrocortisone—NR3C1—smooth muscle tissue—urinary bladder cancer	0.00594	0.0156	CbGeAlD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—ESR2—urinary bladder cancer	0.0059	0.028	CbGpPWpGaD
Fludrocortisone—AR—vagina—urinary bladder cancer	0.00572	0.015	CbGeAlD
Fludrocortisone—NR3C1—renal system—urinary bladder cancer	0.00572	0.015	CbGeAlD
Fludrocortisone—NR3C1—urethra—urinary bladder cancer	0.00562	0.0147	CbGeAlD
Fludrocortisone—Skin hyperpigmentation—Fluorouracil—urinary bladder cancer	0.00548	0.0136	CcSEcCtD
Fludrocortisone—NR3C1—Signaling events mediated by HDAC Class II—HDAC4—urinary bladder cancer	0.00542	0.0257	CbGpPWpGaD
Fludrocortisone—Diabetic—Methotrexate—urinary bladder cancer	0.00508	0.0126	CcSEcCtD
Fludrocortisone—Optic neuritis—Cisplatin—urinary bladder cancer	0.00502	0.0125	CcSEcCtD
Fludrocortisone—NR3C2—lymph node—urinary bladder cancer	0.005	0.0131	CbGeAlD
Fludrocortisone—Optic neuritis—Etoposide—urinary bladder cancer	0.0046	0.0114	CcSEcCtD
Fludrocortisone—NR3C1—female reproductive system—urinary bladder cancer	0.00458	0.012	CbGeAlD
Fludrocortisone—Osteonecrosis—Methotrexate—urinary bladder cancer	0.00455	0.0113	CcSEcCtD
Fludrocortisone—Amenorrhoea—Thiotepa—urinary bladder cancer	0.00449	0.0111	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Gemcitabine—urinary bladder cancer	0.00448	0.0111	CcSEcCtD
Fludrocortisone—Cardiomegaly—Epirubicin—urinary bladder cancer	0.00435	0.0108	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—PHB—urinary bladder cancer	0.00432	0.0205	CbGpPWpGaD
Fludrocortisone—Myalgia—Valrubicin—urinary bladder cancer	0.00423	0.0105	CcSEcCtD
Fludrocortisone—NR3C1—vagina—urinary bladder cancer	0.00414	0.0109	CbGeAlD
Fludrocortisone—Cataract—Thiotepa—urinary bladder cancer	0.00414	0.0103	CcSEcCtD
Fludrocortisone—Petechiae—Gemcitabine—urinary bladder cancer	0.00403	0.01	CcSEcCtD
Fludrocortisone—Cardiomegaly—Doxorubicin—urinary bladder cancer	0.00402	0.01	CcSEcCtD
Fludrocortisone—Impaired healing—Methotrexate—urinary bladder cancer	0.00392	0.00974	CcSEcCtD
Fludrocortisone—Fluid retention—Thiotepa—urinary bladder cancer	0.00374	0.00929	CcSEcCtD
Fludrocortisone—Infection—Carboplatin—urinary bladder cancer	0.00373	0.00928	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—KRT5—urinary bladder cancer	0.00371	0.0176	CbGpPWpGaD
Fludrocortisone—AR—lymph node—urinary bladder cancer	0.0037	0.0097	CbGeAlD
Fludrocortisone—Musculoskeletal discomfort—Valrubicin—urinary bladder cancer	0.0037	0.00919	CcSEcCtD
Fludrocortisone—Oesophagitis—Thiotepa—urinary bladder cancer	0.0036	0.00895	CcSEcCtD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—ESR1—urinary bladder cancer	0.00358	0.017	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptors—ESR2—urinary bladder cancer	0.00346	0.0164	CbGpPWpGaD
Fludrocortisone—Erythema—Mitomycin—urinary bladder cancer	0.00343	0.00851	CcSEcCtD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—PPARG—urinary bladder cancer	0.00326	0.0155	CbGpPWpGaD
Fludrocortisone—Fluid retention—Gemcitabine—urinary bladder cancer	0.00315	0.00782	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MT2A—urinary bladder cancer	0.00313	0.0148	CbGpPWpGaD
Fludrocortisone—Osteoporosis—Methotrexate—urinary bladder cancer	0.00302	0.00751	CcSEcCtD
Fludrocortisone—Hypernatraemia—Epirubicin—urinary bladder cancer	0.00302	0.0075	CcSEcCtD
Fludrocortisone—Oesophagitis—Fluorouracil—urinary bladder cancer	0.00298	0.0074	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Fluorouracil—urinary bladder cancer	0.00296	0.00736	CcSEcCtD
Fludrocortisone—Hypertension—Mitomycin—urinary bladder cancer	0.00296	0.00735	CcSEcCtD
Fludrocortisone—Fluid retention—Cisplatin—urinary bladder cancer	0.00293	0.00729	CcSEcCtD
Fludrocortisone—Multiple fractures—Methotrexate—urinary bladder cancer	0.00292	0.00725	CcSEcCtD
Fludrocortisone—Fracture—Methotrexate—urinary bladder cancer	0.00292	0.00725	CcSEcCtD
Fludrocortisone—Asthenia—Valrubicin—urinary bladder cancer	0.00291	0.00723	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Methotrexate—urinary bladder cancer	0.00285	0.00708	CcSEcCtD
Fludrocortisone—NR3C2—Preimplantation Embryo—CDH1—urinary bladder cancer	0.00281	0.0133	CbGpPWpGaD
Fludrocortisone—Oedema—Mitomycin—urinary bladder cancer	0.0028	0.00695	CcSEcCtD
Fludrocortisone—Hypernatraemia—Doxorubicin—urinary bladder cancer	0.00279	0.00694	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—ESR2—urinary bladder cancer	0.00274	0.013	CbGpPWpGaD
Fludrocortisone—Thrombophlebitis—Fluorouracil—urinary bladder cancer	0.00273	0.00679	CcSEcCtD
Fludrocortisone—NR3C1—lymph node—urinary bladder cancer	0.00268	0.00702	CbGeAlD
Fludrocortisone—Skin hyperpigmentation—Epirubicin—urinary bladder cancer	0.00267	0.00663	CcSEcCtD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—urinary bladder cancer	0.00265	0.0126	CbGpPWpGaD
Fludrocortisone—Cardiac failure congestive—Gemcitabine—urinary bladder cancer	0.00265	0.00659	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptors—ESR2—urinary bladder cancer	0.00263	0.0125	CbGpPWpGaD
Fludrocortisone—Oesophagitis—Etoposide—urinary bladder cancer	0.00259	0.00643	CcSEcCtD
Fludrocortisone—Optic neuritis—Epirubicin—urinary bladder cancer	0.00258	0.00641	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Etoposide—urinary bladder cancer	0.00257	0.00639	CcSEcCtD
Fludrocortisone—Headache—Valrubicin—urinary bladder cancer	0.00254	0.00632	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Gemcitabine—urinary bladder cancer	0.00249	0.00618	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Cisplatin—urinary bladder cancer	0.00247	0.00614	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Doxorubicin—urinary bladder cancer	0.00247	0.00613	CcSEcCtD
Fludrocortisone—Optic neuritis—Doxorubicin—urinary bladder cancer	0.00239	0.00593	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Cisplatin—urinary bladder cancer	0.00232	0.00576	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Etoposide—urinary bladder cancer	0.00227	0.00563	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—NCOR1—urinary bladder cancer	0.00226	0.0107	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—urinary bladder cancer	0.00225	0.0107	CbGpPWpGaD
Fludrocortisone—Hyperglycaemia—Thiotepa—urinary bladder cancer	0.00223	0.00554	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Epirubicin—urinary bladder cancer	0.00214	0.00533	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Etoposide—urinary bladder cancer	0.00212	0.00527	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptors—ESR1—urinary bladder cancer	0.0021	0.00996	CbGpPWpGaD
Fludrocortisone—Muscular weakness—Fluorouracil—urinary bladder cancer	0.00209	0.00518	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—ESR2—urinary bladder cancer	0.00208	0.00985	CbGpPWpGaD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—urinary bladder cancer	0.00207	0.00983	CbGpPWpGaD
Fludrocortisone—Petechiae—Methotrexate—urinary bladder cancer	0.00206	0.00512	CcSEcCtD
Fludrocortisone—Asthenia—Mitomycin—urinary bladder cancer	0.00201	0.00498	CcSEcCtD
Fludrocortisone—Haemoglobin—Thiotepa—urinary bladder cancer	0.00199	0.00494	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Doxorubicin—urinary bladder cancer	0.00198	0.00493	CcSEcCtD
Fludrocortisone—Haemorrhage—Thiotepa—urinary bladder cancer	0.00198	0.00492	CcSEcCtD
Fludrocortisone—Glycosuria—Epirubicin—urinary bladder cancer	0.00196	0.00487	CcSEcCtD
Fludrocortisone—Petechiae—Epirubicin—urinary bladder cancer	0.00193	0.00479	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptors—PPARG—urinary bladder cancer	0.00192	0.00909	CbGpPWpGaD
Fludrocortisone—Pancreatitis—Cisplatin—urinary bladder cancer	0.0019	0.00472	CcSEcCtD
Fludrocortisone—Sweating increased—Cisplatin—urinary bladder cancer	0.00189	0.00469	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Gemcitabine—urinary bladder cancer	0.00188	0.00466	CcSEcCtD
Fludrocortisone—AR—FOXA1 transcription factor network—ESR1—urinary bladder cancer	0.00187	0.00886	CbGpPWpGaD
Fludrocortisone—Glycosuria—Doxorubicin—urinary bladder cancer	0.00181	0.0045	CcSEcCtD
Fludrocortisone—Amenorrhoea—Epirubicin—urinary bladder cancer	0.00181	0.00449	CcSEcCtD
Fludrocortisone—Petechiae—Doxorubicin—urinary bladder cancer	0.00178	0.00443	CcSEcCtD
Fludrocortisone—Headache—Mitomycin—urinary bladder cancer	0.00175	0.00435	CcSEcCtD
Fludrocortisone—Sweating increased—Etoposide—urinary bladder cancer	0.00173	0.0043	CcSEcCtD
Fludrocortisone—Erythema—Thiotepa—urinary bladder cancer	0.00172	0.00428	CcSEcCtD
Fludrocortisone—Haemoglobin—Gemcitabine—urinary bladder cancer	0.00167	0.00416	CcSEcCtD
Fludrocortisone—Amenorrhoea—Doxorubicin—urinary bladder cancer	0.00167	0.00415	CcSEcCtD
Fludrocortisone—Haemorrhage—Gemcitabine—urinary bladder cancer	0.00166	0.00414	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—ESR1—urinary bladder cancer	0.00166	0.00787	CbGpPWpGaD
Fludrocortisone—Haemoglobin—Fluorouracil—urinary bladder cancer	0.00165	0.00409	CcSEcCtD
Fludrocortisone—AR—FOXA1 transcription factor network—CREBBP—urinary bladder cancer	0.00164	0.00777	CbGpPWpGaD
Fludrocortisone—Haemorrhage—Fluorouracil—urinary bladder cancer	0.00164	0.00407	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptors—ESR1—urinary bladder cancer	0.00159	0.00756	CbGpPWpGaD
Fludrocortisone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—urinary bladder cancer	0.00159	0.00756	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.00156	0.0074	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—CREBBP—urinary bladder cancer	0.00155	0.00737	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—RB1—urinary bladder cancer	0.00155	0.00734	CbGpPWpGaD
Fludrocortisone—Neoplasm—Methotrexate—urinary bladder cancer	0.00153	0.00381	CcSEcCtD
Fludrocortisone—Ecchymosis—Methotrexate—urinary bladder cancer	0.00153	0.00381	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—PPARG—urinary bladder cancer	0.00151	0.00718	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—NCOR1—urinary bladder cancer	0.00151	0.00716	CbGpPWpGaD
Fludrocortisone—Fluid retention—Epirubicin—urinary bladder cancer	0.00151	0.00374	CcSEcCtD
Fludrocortisone—Convulsion—Thiotepa—urinary bladder cancer	0.00149	0.00371	CcSEcCtD
Fludrocortisone—Hypertension—Thiotepa—urinary bladder cancer	0.00149	0.0037	CcSEcCtD
Fludrocortisone—Myalgia—Thiotepa—urinary bladder cancer	0.00147	0.00364	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—NCOR1—urinary bladder cancer	0.00146	0.00692	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptors—PPARG—urinary bladder cancer	0.00145	0.0069	CbGpPWpGaD
Fludrocortisone—Oesophagitis—Epirubicin—urinary bladder cancer	0.00145	0.0036	CcSEcCtD
Fludrocortisone—Erythema—Gemcitabine—urinary bladder cancer	0.00145	0.0036	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Epirubicin—urinary bladder cancer	0.00144	0.00358	CcSEcCtD
Fludrocortisone—AR—Nongenotropic Androgen signaling—SRC—urinary bladder cancer	0.00144	0.00681	CbGpPWpGaD
Fludrocortisone—Neoplasm—Epirubicin—urinary bladder cancer	0.00143	0.00356	CcSEcCtD
Fludrocortisone—Ecchymosis—Epirubicin—urinary bladder cancer	0.00143	0.00356	CcSEcCtD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—urinary bladder cancer	0.00143	0.00677	CbGpPWpGaD
Fludrocortisone—Erythema—Fluorouracil—urinary bladder cancer	0.00142	0.00354	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Methotrexate—urinary bladder cancer	0.00142	0.00353	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Methotrexate—urinary bladder cancer	0.00142	0.00352	CcSEcCtD
Fludrocortisone—AR—Regulation of Androgen receptor activity—CREBBP—urinary bladder cancer	0.00141	0.00669	CbGpPWpGaD
Fludrocortisone—Fluoxymesterone—ESR1—urinary bladder cancer	0.00141	0.29	CrCbGaD
Fludrocortisone—Infection—Thiotepa—urinary bladder cancer	0.0014	0.00347	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—CCNE1—urinary bladder cancer	0.00139	0.00661	CbGpPWpGaD
Fludrocortisone—Fluid retention—Doxorubicin—urinary bladder cancer	0.00139	0.00346	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—NCOR1—urinary bladder cancer	0.00135	0.00642	CbGpPWpGaD
Fludrocortisone—Erythema—Cisplatin—urinary bladder cancer	0.00135	0.00336	CcSEcCtD
Fludrocortisone—Oesophagitis—Doxorubicin—urinary bladder cancer	0.00134	0.00333	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Doxorubicin—urinary bladder cancer	0.00133	0.00332	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Epirubicin—urinary bladder cancer	0.00133	0.00331	CcSEcCtD
Fludrocortisone—Ecchymosis—Doxorubicin—urinary bladder cancer	0.00133	0.0033	CcSEcCtD
Fludrocortisone—Neoplasm—Doxorubicin—urinary bladder cancer	0.00133	0.0033	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Epirubicin—urinary bladder cancer	0.00132	0.00329	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—urinary bladder cancer	0.0013	0.00616	CbGpPWpGaD
Fludrocortisone—Vascular purpura—Epirubicin—urinary bladder cancer	0.00129	0.0032	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.00128	0.00318	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TSC1—urinary bladder cancer	0.00128	0.00607	CbGpPWpGaD
Fludrocortisone—Anaphylactoid reaction—Methotrexate—urinary bladder cancer	0.00127	0.00316	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Epirubicin—urinary bladder cancer	0.00127	0.00316	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—ESR1—urinary bladder cancer	0.00126	0.00597	CbGpPWpGaD
Fludrocortisone—Hypertension—Gemcitabine—urinary bladder cancer	0.00125	0.00311	CcSEcCtD
Fludrocortisone—Convulsion—Fluorouracil—urinary bladder cancer	0.00123	0.00307	CcSEcCtD
Fludrocortisone—Myalgia—Gemcitabine—urinary bladder cancer	0.00123	0.00307	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Doxorubicin—urinary bladder cancer	0.00123	0.00306	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Doxorubicin—urinary bladder cancer	0.00123	0.00304	CcSEcCtD
Fludrocortisone—Myalgia—Fluorouracil—urinary bladder cancer	0.00121	0.00301	CcSEcCtD
Fludrocortisone—Medroxyprogesterone Acetate—ESR1—urinary bladder cancer	0.00121	0.249	CrCbGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—TNF—urinary bladder cancer	0.0012	0.00567	CbGpPWpGaD
Fludrocortisone—Purpura—Epirubicin—urinary bladder cancer	0.0012	0.00297	CcSEcCtD
Fludrocortisone—Vascular purpura—Doxorubicin—urinary bladder cancer	0.00119	0.00296	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Epirubicin—urinary bladder cancer	0.00119	0.00296	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.00119	0.00564	CbGpPWpGaD
Fludrocortisone—Oedema—Gemcitabine—urinary bladder cancer	0.00118	0.00294	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.00118	0.00294	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.00118	0.00561	CbGpPWpGaD
Fludrocortisone—Cardiac failure congestive—Doxorubicin—urinary bladder cancer	0.00118	0.00292	CcSEcCtD
Fludrocortisone—Infection—Gemcitabine—urinary bladder cancer	0.00117	0.00292	CcSEcCtD
Fludrocortisone—Convulsion—Cisplatin—urinary bladder cancer	0.00117	0.00291	CcSEcCtD
Fludrocortisone—Mood swings—Methotrexate—urinary bladder cancer	0.00117	0.0029	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00116	0.00289	CcSEcCtD
Fludrocortisone—Oedema—Fluorouracil—urinary bladder cancer	0.00116	0.00289	CcSEcCtD
Fludrocortisone—Infection—Fluorouracil—urinary bladder cancer	0.00116	0.00287	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—urinary bladder cancer	0.00115	0.00546	CbGpPWpGaD
Fludrocortisone—Myalgia—Cisplatin—urinary bladder cancer	0.00115	0.00286	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—PPARG—urinary bladder cancer	0.00115	0.00545	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—urinary bladder cancer	0.00115	0.00544	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00114	0.00284	CcSEcCtD
Fludrocortisone—Affect lability—Epirubicin—urinary bladder cancer	0.00113	0.00282	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.00112	0.00531	CbGpPWpGaD
Fludrocortisone—Urticaria—Thiotepa—urinary bladder cancer	0.00112	0.00277	CcSEcCtD
Fludrocortisone—AR—FOXA1 transcription factor network—EP300—urinary bladder cancer	0.00112	0.00529	CbGpPWpGaD
Fludrocortisone—Vertigo—Etoposide—urinary bladder cancer	0.00111	0.00276	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—urinary bladder cancer	0.00111	0.00525	CbGpPWpGaD
Fludrocortisone—Purpura—Doxorubicin—urinary bladder cancer	0.00111	0.00275	CcSEcCtD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CDKN2A—urinary bladder cancer	0.0011	0.00524	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.0011	0.00274	CcSEcCtD
Fludrocortisone—Oedema—Cisplatin—urinary bladder cancer	0.0011	0.00274	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.0011	0.00274	CcSEcCtD
Fludrocortisone—Infection—Cisplatin—urinary bladder cancer	0.0011	0.00272	CcSEcCtD
Fludrocortisone—Mood swings—Epirubicin—urinary bladder cancer	0.00109	0.00271	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00108	0.00268	CcSEcCtD
Fludrocortisone—Convulsion—Etoposide—urinary bladder cancer	0.00107	0.00266	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—CREBBP—urinary bladder cancer	0.00107	0.00508	CbGpPWpGaD
Fludrocortisone—Insomnia—Gemcitabine—urinary bladder cancer	0.00107	0.00266	CcSEcCtD
Fludrocortisone—Hypertension—Etoposide—urinary bladder cancer	0.00107	0.00265	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00107	0.00265	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00106	0.00263	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—EP300—urinary bladder cancer	0.00106	0.00502	CbGpPWpGaD
Fludrocortisone—Insomnia—Fluorouracil—urinary bladder cancer	0.00105	0.00261	CcSEcCtD
Fludrocortisone—Affect lability—Doxorubicin—urinary bladder cancer	0.00105	0.00261	CcSEcCtD
Fludrocortisone—Pancreatitis—Methotrexate—urinary bladder cancer	0.00104	0.00259	CcSEcCtD
Fludrocortisone—NR3C1—Circadian Clock—CREBBP—urinary bladder cancer	0.00104	0.00493	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—PLAU—urinary bladder cancer	0.00104	0.00493	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00104	0.00257	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.00102	0.00483	CbGpPWpGaD
Fludrocortisone—Muscular weakness—Epirubicin—urinary bladder cancer	0.00102	0.00252	CcSEcCtD
Fludrocortisone—AR—Nongenotropic Androgen signaling—HRAS—urinary bladder cancer	0.00101	0.00479	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00101	0.00251	CcSEcCtD
Fludrocortisone—Mood swings—Doxorubicin—urinary bladder cancer	0.00101	0.00251	CcSEcCtD
Fludrocortisone—Asthenia—Thiotepa—urinary bladder cancer	0.00101	0.00251	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—urinary bladder cancer	0.00101	0.00478	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—CREBBP—urinary bladder cancer	0.00101	0.00477	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.001	0.0025	CcSEcCtD
Fludrocortisone—Infection—Etoposide—urinary bladder cancer	0.001	0.00249	CcSEcCtD
Fludrocortisone—Abdominal distension—Epirubicin—urinary bladder cancer	0.001	0.00249	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—ESR1—urinary bladder cancer	0.000978	0.00464	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000976	0.00243	CcSEcCtD
Fludrocortisone—Pancreatitis—Epirubicin—urinary bladder cancer	0.000976	0.00242	CcSEcCtD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—urinary bladder cancer	0.000972	0.00461	CbGpPWpGaD
Fludrocortisone—AR—Regulation of Androgen receptor activity—EP300—urinary bladder cancer	0.000961	0.00456	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000952	0.00451	CbGpPWpGaD
Fludrocortisone—Muscular weakness—Doxorubicin—urinary bladder cancer	0.00094	0.00234	CcSEcCtD
Fludrocortisone—AR—Regulation of Androgen receptor activity—SRC—urinary bladder cancer	0.000935	0.00443	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CCND1—urinary bladder cancer	0.000933	0.00442	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CREBBP—urinary bladder cancer	0.000932	0.00442	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—RB1—urinary bladder cancer	0.000929	0.0044	CbGpPWpGaD
Fludrocortisone—Abdominal distension—Doxorubicin—urinary bladder cancer	0.000927	0.0023	CcSEcCtD
Fludrocortisone—Urticaria—Fluorouracil—urinary bladder cancer	0.000924	0.0023	CcSEcCtD
Fludrocortisone—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000903	0.00224	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.000898	0.00223	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—urinary bladder cancer	0.000889	0.00422	CbGpPWpGaD
Fludrocortisone—Headache—Thiotepa—urinary bladder cancer	0.000881	0.00219	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—urinary bladder cancer	0.000874	0.00414	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—urinary bladder cancer	0.00087	0.00413	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000857	0.00213	CcSEcCtD
Fludrocortisone—Haemoglobin—Methotrexate—urinary bladder cancer	0.000856	0.00213	CcSEcCtD
Fludrocortisone—Haemorrhage—Methotrexate—urinary bladder cancer	0.000851	0.00212	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.000849	0.00403	CbGpPWpGaD
Fludrocortisone—Asthenia—Gemcitabine—urinary bladder cancer	0.000849	0.00211	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—RHOA—urinary bladder cancer	0.000843	0.004	CbGpPWpGaD
Fludrocortisone—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000831	0.00206	CcSEcCtD
Fludrocortisone—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000812	0.00202	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—urinary bladder cancer	0.000806	0.00382	CbGpPWpGaD
Fludrocortisone—Urticaria—Etoposide—urinary bladder cancer	0.000802	0.00199	CcSEcCtD
Fludrocortisone—Haemoglobin—Epirubicin—urinary bladder cancer	0.000801	0.00199	CcSEcCtD
Fludrocortisone—Haemorrhage—Epirubicin—urinary bladder cancer	0.000797	0.00198	CcSEcCtD
Fludrocortisone—Asthenia—Cisplatin—urinary bladder cancer	0.000791	0.00196	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000787	0.00373	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—urinary bladder cancer	0.000762	0.00362	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—NCOR1—urinary bladder cancer	0.000759	0.0036	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.000757	0.00359	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—urinary bladder cancer	0.000755	0.00358	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—urinary bladder cancer	0.000751	0.00356	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CDKN2A—urinary bladder cancer	0.00075	0.00356	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Etoposide—urinary bladder cancer	0.000744	0.00185	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.000744	0.00353	CbGpPWpGaD
Fludrocortisone—Erythema—Methotrexate—urinary bladder cancer	0.000741	0.00184	CcSEcCtD
Fludrocortisone—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000741	0.00184	CcSEcCtD
Fludrocortisone—Headache—Gemcitabine—urinary bladder cancer	0.000741	0.00184	CcSEcCtD
Fludrocortisone—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000737	0.00183	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—urinary bladder cancer	0.000729	0.00346	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—EP300—urinary bladder cancer	0.000729	0.00346	CbGpPWpGaD
Fludrocortisone—Headache—Fluorouracil—urinary bladder cancer	0.000729	0.00181	CcSEcCtD
Fludrocortisone—Asthenia—Etoposide—urinary bladder cancer	0.000725	0.0018	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—urinary bladder cancer	0.000719	0.00341	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—SRC—urinary bladder cancer	0.000709	0.00336	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—EP300—urinary bladder cancer	0.000708	0.00336	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—ATM—urinary bladder cancer	0.000703	0.00333	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CDK4—urinary bladder cancer	0.0007	0.00332	CbGpPWpGaD
Fludrocortisone—Progesterone—ESR1—urinary bladder cancer	0.000699	0.144	CrCbGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—ESR1—urinary bladder cancer	0.000697	0.0033	CbGpPWpGaD
Fludrocortisone—Erythema—Epirubicin—urinary bladder cancer	0.000694	0.00172	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—urinary bladder cancer	0.000691	0.00328	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CCND1—urinary bladder cancer	0.00069	0.00327	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—urinary bladder cancer	0.000684	0.00325	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CXCL8—urinary bladder cancer	0.000681	0.00323	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—FAS—urinary bladder cancer	0.00068	0.00322	CbGpPWpGaD
Fludrocortisone—Triamcinolone—PTGS2—urinary bladder cancer	0.00067	0.138	CrCbGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CDKN1A—urinary bladder cancer	0.000667	0.00316	CbGpPWpGaD
Fludrocortisone—Vertigo—Methotrexate—urinary bladder cancer	0.000666	0.00165	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—PTEN—urinary bladder cancer	0.000666	0.00316	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.000659	0.00312	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL2—urinary bladder cancer	0.00065	0.00308	CbGpPWpGaD
Fludrocortisone—Convulsion—Methotrexate—urinary bladder cancer	0.000642	0.0016	CcSEcCtD
Fludrocortisone—Erythema—Doxorubicin—urinary bladder cancer	0.000642	0.00159	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—EP300—urinary bladder cancer	0.000635	0.00301	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CCND1—urinary bladder cancer	0.000634	0.00301	CbGpPWpGaD
Fludrocortisone—Headache—Etoposide—urinary bladder cancer	0.000633	0.00157	CcSEcCtD
Fludrocortisone—Myalgia—Methotrexate—urinary bladder cancer	0.000631	0.00157	CcSEcCtD
Fludrocortisone—Vertigo—Epirubicin—urinary bladder cancer	0.000623	0.00155	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.000618	0.00293	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—SRC—urinary bladder cancer	0.000617	0.00293	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MMP9—urinary bladder cancer	0.000616	0.00292	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—PTEN—urinary bladder cancer	0.000612	0.0029	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—RB1—urinary bladder cancer	0.000608	0.00288	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CDH1—urinary bladder cancer	0.000606	0.00287	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000605	0.0015	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—urinary bladder cancer	0.000602	0.00286	CbGpPWpGaD
Fludrocortisone—Convulsion—Epirubicin—urinary bladder cancer	0.000601	0.00149	CcSEcCtD
Fludrocortisone—Infection—Methotrexate—urinary bladder cancer	0.000601	0.00149	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—urinary bladder cancer	0.0006	0.00284	CbGpPWpGaD
Fludrocortisone—Hypertension—Epirubicin—urinary bladder cancer	0.000599	0.00149	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—urinary bladder cancer	0.000596	0.00283	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.000595	0.00282	CbGpPWpGaD
Fludrocortisone—Myalgia—Epirubicin—urinary bladder cancer	0.000591	0.00147	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000585	0.00145	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—EP300—urinary bladder cancer	0.000584	0.00277	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.000582	0.00276	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.00058	0.00275	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	0.000577	0.00274	CbGpPWpGaD
Fludrocortisone—Vertigo—Doxorubicin—urinary bladder cancer	0.000577	0.00143	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL2—urinary bladder cancer	0.000573	0.00272	CbGpPWpGaD
Fludrocortisone—Oedema—Epirubicin—urinary bladder cancer	0.000566	0.00141	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000566	0.00141	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000564	0.00267	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—SMC1A—urinary bladder cancer	0.000563	0.00267	CbGpPWpGaD
Fludrocortisone—Infection—Epirubicin—urinary bladder cancer	0.000562	0.0014	CcSEcCtD
Fludrocortisone—Convulsion—Doxorubicin—urinary bladder cancer	0.000556	0.00138	CcSEcCtD
Fludrocortisone—Hypertension—Doxorubicin—urinary bladder cancer	0.000554	0.00138	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000551	0.00137	CcSEcCtD
Fludrocortisone—Betamethasone—PTGS2—urinary bladder cancer	0.000549	0.113	CrCbGaD
Fludrocortisone—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000547	0.00136	CcSEcCtD
Fludrocortisone—Insomnia—Methotrexate—urinary bladder cancer	0.000547	0.00136	CcSEcCtD
Fludrocortisone—Myalgia—Doxorubicin—urinary bladder cancer	0.000546	0.00136	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—urinary bladder cancer	0.000546	0.00259	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—PPARG—urinary bladder cancer	0.000544	0.00258	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000542	0.00257	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—EGFR—urinary bladder cancer	0.000541	0.00257	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—urinary bladder cancer	0.00054	0.00256	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000524	0.0013	CcSEcCtD
Fludrocortisone—Oedema—Doxorubicin—urinary bladder cancer	0.000524	0.0013	CcSEcCtD
Fludrocortisone—Infection—Doxorubicin—urinary bladder cancer	0.00052	0.00129	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—RB1—urinary bladder cancer	0.00052	0.00247	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—urinary bladder cancer	0.000519	0.00246	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000516	0.00128	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—IGF1—urinary bladder cancer	0.000516	0.00245	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—EP300—urinary bladder cancer	0.000514	0.00244	CbGpPWpGaD
Fludrocortisone—Insomnia—Epirubicin—urinary bladder cancer	0.000512	0.00127	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MYC—urinary bladder cancer	0.000509	0.00241	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000506	0.00126	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.000506	0.0024	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.0005	0.00237	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—ESR2—urinary bladder cancer	0.000491	0.00233	CbGpPWpGaD
Fludrocortisone—Urticaria—Methotrexate—urinary bladder cancer	0.000481	0.00119	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000477	0.00119	CcSEcCtD
Fludrocortisone—Insomnia—Doxorubicin—urinary bladder cancer	0.000474	0.00118	CcSEcCtD
Fludrocortisone—AR—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000473	0.00224	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000472	0.00224	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—urinary bladder cancer	0.000453	0.00215	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CCND1—urinary bladder cancer	0.000452	0.00214	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.000451	0.00214	CbGpPWpGaD
Fludrocortisone—Urticaria—Epirubicin—urinary bladder cancer	0.00045	0.00112	CcSEcCtD
Fludrocortisone—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000446	0.00111	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—PTEN—urinary bladder cancer	0.000436	0.00207	CbGpPWpGaD
Fludrocortisone—Asthenia—Methotrexate—urinary bladder cancer	0.000434	0.00108	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	0.000424	0.00201	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TP53—urinary bladder cancer	0.000418	0.00198	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000417	0.00104	CcSEcCtD
Fludrocortisone—Urticaria—Doxorubicin—urinary bladder cancer	0.000416	0.00103	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—EP300—urinary bladder cancer	0.000416	0.00197	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	0.000414	0.00196	CbGpPWpGaD
Fludrocortisone—Asthenia—Epirubicin—urinary bladder cancer	0.000406	0.00101	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000405	0.00192	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000386	0.000959	CcSEcCtD
Fludrocortisone—Headache—Methotrexate—urinary bladder cancer	0.000379	0.000941	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—NCOR1—urinary bladder cancer	0.000379	0.0018	CbGpPWpGaD
Fludrocortisone—Asthenia—Doxorubicin—urinary bladder cancer	0.000376	0.000934	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	0.000374	0.00178	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—CDKN1A—urinary bladder cancer	0.000374	0.00177	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—urinary bladder cancer	0.000368	0.00174	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000365	0.00173	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MYC—urinary bladder cancer	0.000362	0.00172	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	0.000362	0.00172	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	0.000361	0.00171	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000359	0.0017	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000358	0.0017	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—ERCC2—urinary bladder cancer	0.000356	0.00169	CbGpPWpGaD
Fludrocortisone—Headache—Epirubicin—urinary bladder cancer	0.000355	0.000881	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—EGFR—urinary bladder cancer	0.000354	0.00168	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	0.000345	0.00163	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	0.000335	0.00159	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	0.000335	0.00159	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000329	0.00156	CbGpPWpGaD
Fludrocortisone—Headache—Doxorubicin—urinary bladder cancer	0.000328	0.000815	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—MYC—urinary bladder cancer	0.000321	0.00152	CbGpPWpGaD
Fludrocortisone—Dexamethasone—PTGS2—urinary bladder cancer	0.000319	0.0657	CrCbGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000307	0.00146	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	0.0003	0.00142	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	0.000298	0.00141	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—ESR1—urinary bladder cancer	0.000298	0.00141	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	0.000294	0.00139	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—TNF—urinary bladder cancer	0.000289	0.00137	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.000287	0.00136	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	0.00028	0.00133	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	0.000277	0.00132	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000277	0.00131	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PPARG—urinary bladder cancer	0.000271	0.00129	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000262	0.00124	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—SMC1A—urinary bladder cancer	0.000261	0.00124	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—CREBBP—urinary bladder cancer	0.000261	0.00124	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000251	0.00119	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.00025	0.00118	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	0.000247	0.00117	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—ESR2—urinary bladder cancer	0.000228	0.00108	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.000218	0.00103	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000199	0.000941	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—SMC1A—urinary bladder cancer	0.000198	0.00094	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000191	0.000904	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NCOR1—urinary bladder cancer	0.000176	0.000833	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—ESR2—urinary bladder cancer	0.000173	0.000819	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—ERCC2—urinary bladder cancer	0.000165	0.000784	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—MYC—urinary bladder cancer	0.000155	0.000734	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—MYC—urinary bladder cancer	0.000149	0.000707	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—ESR1—urinary bladder cancer	0.000138	0.000655	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NCOR1—urinary bladder cancer	0.000133	0.000632	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PPARG—urinary bladder cancer	0.000126	0.000597	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—ERCC2—urinary bladder cancer	0.000125	0.000595	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—CREBBP—urinary bladder cancer	0.000121	0.000574	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—MYC—urinary bladder cancer	0.000113	0.000537	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—ESR1—urinary bladder cancer	0.000105	0.000497	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PPARG—urinary bladder cancer	9.56e-05	0.000453	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—CREBBP—urinary bladder cancer	9.18e-05	0.000435	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—MYC—urinary bladder cancer	7.18e-05	0.000341	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MYC—urinary bladder cancer	5.45e-05	0.000258	CbGpPWpGaD
